The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

Original languageEnglish (Ireland)
JournalCancers
Volume3
DOIs
Publication statusPublished - 1 Jan 2011

Authors (Note for portal: view the doc link for the full list of authors)

  • Authors
  • van Dijk M, Murphy E, Morrell M , Knapper S , O'Dwyer M, Samali A, Eva Szegezdi E.

Cite this